These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 3941293

  • 1. Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda.
    Rocchi E, Gibertini P, Cassanelli M, Pietrangelo A, Borghi A, Ventura E.
    J Lab Clin Med; 1986 Jan; 107(1):36-42. PubMed ID: 3941293
    [Abstract] [Full Text] [Related]

  • 2. [Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis].
    Gibertini P, Rocchi E, Cassanelli M, Pietrangelo A, Coppini M, Ventura E.
    Minerva Med; 1984 Mar 10; 75(9-10):469-74. PubMed ID: 6709223
    [Abstract] [Full Text] [Related]

  • 3. Liver iron overload and desferrioxamine treatment of porphyria cutanea tarda.
    Rocchi E, Cassanelli M, Borghi A, Paolillo F, Pradelli M, Pellizzardi S, Vezzosi A, Gallo E, Baccarani Contri M, Ventura E.
    Dermatologica; 1991 Mar 10; 182(1):27-31. PubMed ID: 2013352
    [Abstract] [Full Text] [Related]

  • 4. Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion.
    Rocchi E, Gibertini P, Cassanelli M, Pietrangelo A, Borghi A, Pantaleoni M, Jensen J, Ventura E.
    Br J Dermatol; 1986 May 10; 114(5):621-9. PubMed ID: 3718853
    [Abstract] [Full Text] [Related]

  • 5. Advances in the treatment of porphyria cutanea tarda. Effectiveness of slow subcutaneous desferrioxamine infusion.
    Gibertini P, Rocchi E, Cassanelli M, Pietrangelo A, Ventura E.
    Liver; 1984 Aug 10; 4(4):280-4. PubMed ID: 6482687
    [Abstract] [Full Text] [Related]

  • 6. A comparative trial of desferrioxamine and hydroxychloroquine for treatment of porphyria cutanea tarda in alcoholic patients.
    Marchesi L, Di Padova C, Cainelli T, Reseghetti A, Di Padova F, Rovagnati P, Cantoni L.
    Photodermatol; 1984 Dec 10; 1(6):286-92. PubMed ID: 6398430
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis B virus infection in porphyria cutanea tarda.
    Rocchi E, Gibertini P, Cassanelli M, Pietrangelo A, Jensen J, Ventura E.
    Liver; 1986 Jun 10; 6(3):153-7. PubMed ID: 3747744
    [Abstract] [Full Text] [Related]

  • 8. Phlebotomy treatment of porphyria cutanea tarda.
    Lundvall O.
    Acta Derm Venereol Suppl (Stockh); 1982 Jun 10; 100():107-18. PubMed ID: 6962627
    [Abstract] [Full Text] [Related]

  • 9. Porphyria cutanea tarda: clinical and laboratory features.
    Sweeney GD, Jones KG.
    Can Med Assoc J; 1979 Apr 07; 120(7):803-7. PubMed ID: 427687
    [Abstract] [Full Text] [Related]

  • 10. [Determination of blood ferritin in the evaluation of hepatic siderosis in patients with porphyria cutanea tarda].
    Vozza A, Rossi A, Cicala G, Caso R, Esposito P.
    G Ital Dermatol Venereol; 1988 Apr 07; 123(7-8):325-7. PubMed ID: 3224995
    [No Abstract] [Full Text] [Related]

  • 11. Hydroxychloroquine versus phlebotomy in the treatment of porphyria cutanea tarda.
    Cainelli T, Di Padova C, Marchesi L, Gori G, Rovagnati P, Podenzani SA, Bessone E, Cantoni L.
    Br J Dermatol; 1983 May 07; 108(5):593-600. PubMed ID: 6849826
    [Abstract] [Full Text] [Related]

  • 12. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
    Siersema PD, Rademakers LH, Cleton MI, ten Kate FJ, de Bruijn WC, Marx JJ, Wilson JH.
    J Hepatol; 1995 Sep 07; 23(3):259-67. PubMed ID: 8550989
    [Abstract] [Full Text] [Related]

  • 13. Screening of patients with iron overload to identify hemochromatosis and porphyria cutanea tarda.
    O'Reilly FM, Darby C, Fogarty J, Tormey W, Kay EW, Leader M, Murphy GM.
    Arch Dermatol; 1997 Sep 07; 133(9):1098-101. PubMed ID: 9301586
    [Abstract] [Full Text] [Related]

  • 14. The role of iron in experimental porphyria and porphyria cutanea tarda.
    Siersema PD, van Helvoirt RP, Cleton-Soeteman MI, de Bruijn WC, Wilson JH, van Eijk HG.
    Biol Trace Elem Res; 1992 Oct 07; 35(1):65-72. PubMed ID: 1384628
    [Abstract] [Full Text] [Related]

  • 15. Magnetic resonance imaging and different levels of iron overload in chronic liver disease.
    Rocchi E, Cassanelli M, Borghi A, Paolillo F, Pradelli M, Casalgrandi G, Burani A, Gallo E.
    Hepatology; 1993 Jun 07; 17(6):997-1002. PubMed ID: 8514272
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
    Dabrowska E, Jabłońska-Kaszewska I, Bielawski KP, Falkiewicz B.
    Med Sci Monit; 2001 May 07; 7 Suppl 1():190-6. PubMed ID: 12211718
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.